Department of Biomechanical Engineering, University of Twente, Enschede, The Netherlands.
J Tissue Eng Regen Med. 2011 Aug;5(8):e164-7. doi: 10.1002/term.414. Epub 2011 Feb 24.
Clinical translation of engineered tissues into regenerative medicine applications, and the effort to reduce the use of animals for the screening of drugs and other compounds, result in an increasing demand for human tissues engineered in vitro for implantation, in vitro screening systems and basic research. Further development and optimization of in vitro models for quantitative studies of biophysical stimulation and mass transport in engineered tissues is seen as one of the high research priorities. A recent international symposium held in The Netherlands discussed the state of the art and key challenges in the development of bioreactor platforms and microscale technologies. Here we summarize the current status and future development of in vitro tissue models, based on the findings presented at this symposium.
临床翻译工程组织到再生医学应用,以及努力减少动物在药物和其他化合物的筛选中的使用,导致对用于植入、体外筛选系统和基础研究的体外工程人体组织的需求不断增加。进一步开发和优化体外模型,用于定量研究工程组织中的生物物理刺激和质量传递,被视为高度优先的研究重点之一。最近在荷兰举行的一次国际研讨会讨论了生物反应器平台和微尺度技术发展的最新技术和关键挑战。在这里,我们根据本次研讨会的结果,总结了体外组织模型的现状和未来发展。